NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Managing Cancer and Living Meaningfully (CALM) Therapy in Individuals Diagnosed with a Primary Central Nervous System Tumor

This study is NOT currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

000293-C

Sponsoring Institute

National Cancer Institute (NCI)

Recruitment Detail

Type: Clinical hold/Recruitment or enrollment suspended
Gender: Male & Female
Min Age: 18 Years
Max Age: N/A

Referral Letter Required

Yes

Population Exclusion(s)

Non-English Speaking

Keywords

Psychological Distress;
Cancer;
psychotherapy;
virtual therapy;
Telehealth

Recruitment Keyword(s)

None

Condition(s)

Depression

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

Behavioral: CALM Therapy

Supporting Site

National Cancer Institute

Background:

Psychological distress affects many people diagnosed with a primarym central nervous system tumor (CNST). Distress can include negative feelings such as anger, fear, or sadness. Researchers want to see if a type of therapy called CALM can help. It promotes well-being in people who have cancer that cannot be cured.

Objective:

To find out if the CALM therapy can help people with a CNST suffering from distress.

Eligibility:

English-speaking adults ages 18 and older who have a CNST and are taking part in NIH protocol #16C0151.

Design:

This study will not take place in person. It will be done by smartphone, computer, or tablet.

Participants will fill out 7 surveys. The surveys will take 40 to 60 minutes to complete. They are all electronic. They will ask about physical and emotional symptoms, depression, feelings about death and dying, feelings about close relationships, and general well-being.

Participants will be assigned to a CALM therapist. They will have 3 to 6 individual therapy sessions in 6 months. Each session will last 45 to 60 minutes. Sessions may be audio recorded. If needed, participants may have extra sessions.

CALM includes symptom management and discussions of meaning, purpose, and mortality.

Participants may have a family member take part in at least one CALM session with them.

After the third CALM session, participants will be asked questions about CALM.

After 3 and 6 months, participants will complete the 7 surveys again.

Participation will last about 6 months.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

-Subjects with histological or imaging confirmation of PCNST who are undergoing standard of care or experimental treatment.

-Adults (greater than or equal to 18 years of age) who are English-speaking

-Subjects who have a life expectancy of at least 3 months from time of study entry to allow for participation in the 3 required sessions.

-Subjects must be enrolled on the Neuro-Oncology Branch Natural History Study 16C0151.

-The ability of the subject to understand and the willingness to sign a written informed consent document as determined by the assessment of the treating physicians.

EXCLUSION CRITERIA:

-Participants without access to a smartphone, computer, or tablet to complete remote sessions.


--Back to Top--

Citations:

Not Provided

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

Terri S. Armstrong, C.R.N.P.
National Cancer Institute (NCI)
NIHBC 82 - RA BLOCH INTERNATIONAL CANCER CENTER BG RM 201
9030 OLD GEORGETOWN RD
BETHESDA MD 20892
(240) 760-6003
terri.armstrong@nih.gov

Karen J. Evans
National Cancer Institute (NCI)
National Institutes of Health
Building 82
Room 211
9030 Old Georgetown Road
Bethesda, Maryland 20892
(301) 233-8009
evansk3@mail.nih.gov

NCI Referral Office
National Institute of Health Clinical Center (CC), 9000 Rockville Pike, Bethesda, Maryland 20892, United States: NCI Clinical Trials Referral Office
1-888-NCI-1937

Clinical Trials Number:

NCT04852302

--Back to Top--